Erschienen in:
11.03.2021 | Thoracic Oncology
Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma
verfasst von:
Masakazu Goto, MD, PhD, Yukiko Shibahara, MD, PhD, Cristina Baciu, PhD, Frances Allison, BSc, Jonathan C. Yeung, MD, PhD, Gail E. Darling, MD, Mingyao Liu, MD, MSc
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 9/2021
Einloggen, um Zugang zu erhalten
Abstract
Background
Chemokines are major regulators of cell trafficking and adhesion. The chemokine CXCL12 and its receptors, CXCR4 and CXCR7, have been reported as biomarkers in various cancers, including esophageal cancer; however, there are few studies in esophageal adenocarcinoma (EAC). In this study, we investigated the relationship between expression of CXCL12, CXCR4, and CXCR7, and prognosis in patients with EAC.
Methods
This study examined 55 patients with EAC who were treated in Toronto General Hospital from 2001 to 2010. Tissue microarray immunohistochemistry was used to evaluate the expression of CXCL12, CXCR4, and CXCR7. Evaluation of immunohistochemistry was performed by a pathologist without knowledge of patients’ information and results were compared with the patients’ clinicopathological features and survival.
Results
High CXCR7 expression was significantly associated with lymphatic invasion (present vs absent, P = 0.005) and higher number of lymph node metastases (pN0-1 vs pN2-3, P = 0.0014). Patients with high CXCR7 expression (n = 23) were associated with worse overall (OS) and disease-free survival (DFS) (P = 0.0221, P = 0.0090, respectively), and patients with high CXCL12 (n = 24) tended to have worse OS and DFS (P = 0.1091, P = 0.1477, respectively). High expression of both CXCR7 and CXCL12 was an independent prognostic factor for OS and DFS on multivariate analysis (HR = 0.3, 95% CI: 0.1–0.9, P = 0.0246, HR = 0.3, 95% CI: 0.1–0.8, P = 0.0134, respectively).
Conclusions
High CXCR7 expression was associated with poor prognosis in patients with EAC, and high expression of CXCR7 with its ligand CXCL12 had a stronger association with prognosis. Further study of this potential biomarker using whole tissue samples and a larger sample size is warranted.